Our December issue includes Reviews on optimising use of animal models in stone disease, a comprehensive overview of sarcomatoid renal cancer, and surgery for high-risk localized prostate cancer, as well as Comment articles on urology education, environmental plastics and urological cancer, and epigenetic of urothelial carcinoma.

In this issue, you can find Reviews on puberty suppression in young transgender people and targetable gene fusions in genitourinary oncology, as well as Perspectives on screening for renal cancer and autonomous surgery in robotic urology.

In our October issue, you can find Reviews on the genomics and immune environment of penile cancer, depression and prostate cancer, and a comprehensive guide to complicated urinary tract infections.

The September issue includes Perspectives on trained immunity as a mechanism for BCG immunotherapy in bladder cancer and on prostate cancer screening using MRI, as well a Consensus Statement from Movember considering the current landscape of prostate cancer research and identifying unmet research needs in the field.

In this issue: Reviews on the role of the urothelium in urinary tract development, the immune response to infection in the bladder, and intermittent versus continuous androgen deprivation for advanced prostate cancer.

In this issue: Reviews on the genetics of stone disease, sexual function and pelvic organ prolapse and a comprehensive update on compulsive sexual behaviour disorder.

This issue contains Reviews on SPOP and multimodal therapy, a Perspectives introducing PIONEER, a big data project in prostate cancer, and also includes Comments on BCG as a therapy for COVID-19 and The Urinary Tract Infection Global Alliance.

This issue includes Reviews on cellular rewiring in prostate cancer, genomic heterogeneity in bladder cancer and liquid biopsy, as well as a Comment from urologists on the front line of the COVID-19 response in Italy.

This issue contains Reviews on the microbiome of the female reproductive tract and the effect of dysbiosis on malignancy, metabolism in prostate cancer and miRNAs in TGCT.

The March issue includes Reviews on checkpoint inhibitor immunotherapy in kidney cancer, regenerative medicine and injection therapies in stress urinary incontinence and tissue engineering in the management of hypospadias and a Perspective on role of radical prostatectomy in 21st century prostate cancer care.

Our February issue includes Reviews on targeting competitive glucose metabolism to boost bladder cancer immunotherapy, tumour innervation and neurosignalling in prostate cancer and expanding the role of PSMA PET.

The first issue of 2020 includes a Comment from the winners of our cover image competition and Reviews on multiparametric MRI for diagnosis of and financial toxicity associated with prostate cancer and extracellular vesicles in urological malignancies.